Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Kyu Hyung Park, Leonie Tickle & Henry Cutler. (2024) How temporal patterns of medication adherence to antidepressants, bisphosphonates and statins are associated with healthcare cost. Applied Economics 56:11, pages 1283-1308.
Read now
Read now
Fiorenzo Santoleri, Alessia Romagnoli & Alberto Costantini. (2021) Adherence and persistence in the use of statins and ezetimibe over 8 years in a real-life study. Current Medical Research and Opinion 37:12, pages 2061-2066.
Read now
Read now
Peter P Toth, Michael Hull, Craig Granowitz & Sephy Philip. (2021) Real-world Analyses of Patients With Elevated Atherosclerotic Cardiovascular Disease Risk From the Optum Research Database. Future Cardiology 17:4, pages 743-755.
Read now
Read now
Hung-Jen Shih, Pei-Shan Tsai, Yu-Ching Wen, Ming-Chang Kao, Yen-Chun Fan & Chun-Jen Huang. (2020) Hyperlipidemia patients with long-term statin treatment are associated with a reduced risk of progression of benign prostatic enlargement. The Aging Male 23:5, pages 354-361.
Read now
Read now
Aníbal García-Sempere, Isabel Hurtado, José Sanfélix-Genovés, Clara Rodríguez-Bernal, Salvador Peiró & Gabriel Sanfélix-Gimeno. (2019) Improving the accuracy of medication adherence measures using linked prescription and dispensation data: findings from the ESOSVAL cohort of patients treated with osteoporosis drugs. Current Medical Research and Opinion 35:9, pages 1535-1544.
Read now
Read now
Gordon Liu, Jason Shepherd, Pratik Rane, Zhongyun Zhao, Hollie Bailey, Nathan Williams & Yi Qian. (2019) Characteristics of patients with dyslipidemia treated in routine care setting in China. Journal of Drug Assessment 8:1, pages 192-198.
Read now
Read now
Peter Lansberg, Andre Lee, Zhen-Vin Lee, Kannan Subramaniam & Sajita Setia. (2018) Nonadherence to statins: individualized intervention strategies outside the pill box. Vascular Health and Risk Management 14, pages 91-102.
Read now
Read now
R. C. R. M. do Nascimento, A. A. Guerra Jr.J. Alvares, I. C. Gomes, B. Godman, M. Bennie, A. B. Kurdi & F. A. de Acurcio. (2018) Statin use in Brazil: findings and implications. Current Medical Research and Opinion 34:10, pages 1809-1817.
Read now
Read now
Carol A. Forbes, Sohan Deshpande, Francesc Sorio-Vilela, Lucie Kutikova, Steven Duffy, Ioanna Gouni-Berthold & Emil Hagström. (2018) A systematic literature review comparing methods for the measurement of patient persistence and adherence. Current Medical Research and Opinion 34:9, pages 1613-1625.
Read now
Read now
Sofa D. Alfian, Pawida Worawutputtapong, Catharina C. M. Schuiling-Veninga, Jurjen van der Schans, Jens H. J. Bos, Eelko Hak & Petra Denig. (2018) Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands. Current Medical Research and Opinion 34:6, pages 1013-1019.
Read now
Read now
Steven Smith & Jennifer M. Lobo. (2017) Impact statement: “Using claims data linked with electronic health records to monitor and improve adherence to medication”. IISE Transactions on Healthcare Systems Engineering 7:4, pages 193-193.
Read now
Read now
Articles from other publishers (49)
Tomonori Okamura, Kazuhisa Tsukamoto, Hidenori Arai, Yoshio Fujioka, Yasushi Ishigaki, Shinji Koba, Hirotoshi Ohmura, Tetsuo Shoji, Koutaro Yokote, Hiroshi Yoshida, Masayuki Yoshida, Juno Deguchi, Kazushige Dobashi, Akira Fujiyoshi, Hirotoshi Hamaguchi, Masumi Hara, Mariko Harada-Shiba, Takumi Hirata, Mami Iida, Yoshiyuki Ikeda, Shun Ishibashi, Hideyuki Kanda, Shinji Kihara, Kazuo Kitagawa, Satoru Kodama, Masahiro Koseki, Yoshiro Maezawa, Daisaku Masuda, Takashi Miida, Yoshihiro Miyamoto, Rimei Nishimura, Koichi Node, Midori Noguchi, Mitsuru Ohishi, Isao Saito, Shojiro Sawada, Hirohito Sone, Minoru Takemoto, Akihiko Wakatsuki & Hidekatsu Yanai. (2024) Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. Journal of Atherosclerosis and Thrombosis 31:6, pages 641-853.
Crossref
Crossref
Dimitrios Terentes-Printzios, Ioanna Dima, Panorios Benardos, Panagiota Mitrou, Konstantinos Mathioudakis, Anastasios Tsolakidis, Fotios Barkas, Konstantinos Tsioufis, Petros P. Sfikakis, Evangelos Liberopoulos & Charalambos Vlachopoulos. (2024) Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e-prescription database. International Journal of Cardiology Cardiovascular Risk and Prevention 21, pages 200261.
Crossref
Crossref
Karina Kirilova, Indrė Trečiokienė, Nomeda Bratčikovienė, Miriam Qvarnström & Björn Wettermark. (2024) Persistence to statin treatment: A cohort study in Lithuania. Basic & Clinical Pharmacology & Toxicology.
Crossref
Crossref
Przemysław Kardas, Angelika Kwiatek, Piotr Włodarczyk, Filip Urbański & Beata Ciabiada-Bryła. (2024) Statins use amidst the pandemic: prescribing, dispensing, adherence, persistence, and correlation with COVID-19 statistics in nationwide real-world data from Poland. Frontiers in Pharmacology 15.
Crossref
Crossref
Junko Tomida, Tomoji Yoshida, Shoichi Senda, Tsugumichi Sato, Akira Nakatsuma & Naomi Iihara. (2023) Statin persistence and adherence among older initiators: A nationwide cohort study using the national health insurance claims database in Japan. Pharmacoepidemiology and Drug Safety 32:8, pages 873-885.
Crossref
Crossref
Juliana de Oliveira Costa, Jialing Lin, Sallie‐Anne Pearson, Nicholas A. Buckley, Andrea L. Schaffer & Michael O. Falster. (2023) Persistence and Adherence to Cardiovascular Medicines in Australia. Journal of the American Heart Association 12:13.
Crossref
Crossref
Elena A. Okisheva, Olga Iu. Mironova, Maria D. Madoyan, Svetlana E. Fidanyan, Aida I. Semenova, Alexandr S. Panferov, Andrey V. Strokov, Ivan N. Tarabarko, Andrey V. Garkavi, Alexey V. Lychagin & Victor V. Fomin. (2023) Cardiovascular therapy in patients hospitalized for elective large joint arthroplasty: real-world practice review. Consilium Medicum 25:1, pages 34-38.
Crossref
Crossref
Jennifer L. Bacci, Zachary A. Marcum, Patricia Rodriguez, Ryan N. Hansen, Aasthaa Bansal, Tara Pfund, Jenny J. Kim & Peggy Odegard. (2023) Community pharmacist intervention to optimize statin adherence in diabetes care: The GuIDE-S study. Journal of the American Pharmacists Association 63:3, pages 946-951.
Crossref
Crossref
Mario Luca Morieri, Olga Lamacchia, Enzo Manzato, Andrea Giaccari, Angelo Avogaro, Lucio Amoresano, Stefania Angotti, Laura Bartone, Francesco Caraffa, Antonello Carboni, Stefano Carro, Silvestre Cervone, Alessandra Clerico, Ida Console, Danilo Mario Conti, Sergio D’Addato, Alessandra de Bellis, Francesco de Meo, Alberto di Carlo, Graziano di Cianni, Giuseppe di Giovanni, Sergio di Lembo, Fabrizio Diacono, Mara Dolcino, Giovanni Elia, Paolo Elli, Cristina Fatone, Angelica Galli, Giovanni Galluzzo, Adriana Garzaniti, Renata Ghelardi, Anna Giacchini, Loretta Giunta, Francesco Golia, Franco Gregorio, Dario Ierna, Antonio Lampitella, Antonio Luciano, Ada Maffettone, Raffaele Mancini, Ida Mangone, Linneo Enzo Mantovani, Alberto Marangoni, Giuseppe Marelli, Narciso Marin, Gennaro Marino, Eugenio Mastromatteo, Gaetano Mazziotti, Elisa Me, Giuseppe Memoli, Laura Silvia Maria Menicatti, Simona Moffa, Manuela Moise’, Fabrizio Monaco, Sara Nazzarena Morgante, Francesca Pellicano, Ettore Petraroli, Deamaria Piersanti, Antonino Pipitone, Susanna Puglisi, Maura Rinaldi, Mario Rizzo, Maura Rosco, Giampaolo Scollo, Natalino Simioni, Mariarosaria Squadrone, Giacomo Sturniolo, Anna Tedeschi, Biagio Tizio, Diletta Ugolotti, Livio Valente, Carmela Vinci, Luca Zenoni & Maria Grazia Zenti. (2022) Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes. Cardiovascular Diabetology 21:1.
Crossref
Crossref
Xiaowei Yan, Satish Mudiganti, Hannah Husby, Andrew Hudnut, Madina Gbotoe & J. B. Jones. (2022) Medication non-adherence and therapeutic inertia independently contribute to poor disease control for cardiometabolic diseases. Scientific Reports 12:1.
Crossref
Crossref
Faizan Mazhar, Paul Hjemdahl, Catherine M Clase, Kristina Johnell, Tomas Jernberg & Juan Jesus Carrero. (2022) Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease. American Heart Journal 251, pages 78-90.
Crossref
Crossref
Kyu Hyung Park, Leonie Tickle & Henry Cutler. (2022) A systematic review and meta-analysis on impact of suboptimal use of antidepressants, bisphosphonates, and statins on healthcare resource utilisation and healthcare cost. PLOS ONE 17:6, pages e0269836.
Crossref
Crossref
Marjan Farzad, Shima Jafari, Fatemeh Baghernezhad Hesary, Fatemeh Hosseinzadeh Chahkandak, Toba Kazemi, Saeede Khosravi Bizhaem & Farshad Sharifi. (2022) Statin treatment and serum low-density lipoprotein (LDL) level in the Birjand elderly dwellers: Birjand Longitudinal Aging Study (BLAS) Wave3. Journal of Diabetes & Metabolic Disorders 21:1, pages 151-157.
Crossref
Crossref
Andrew Geronimo, Richard M. Albertson, James Noto & Zachary Simmons. (2022) Ten years of riluzole use in a tertiary ALS clinic. Muscle & Nerve 65:6, pages 659-666.
Crossref
Crossref
Irene García-Fernández-Bravo, Ana Torres-Do-Rego, Antonio López-Farré, Francisco Galeano-Valle, Pablo Demelo-Rodriguez & Luis A. Alvarez-Sala-Walther. (2022) Undertreatment or Overtreatment With Statins: Where Are We?. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Kyu Hyung Park, Leonie Tickle & Henry Cutler. (2022) Identifying temporal patterns of adherence to antidepressants, bisphosphonates and statins, and associated patient factors. SSM - Population Health 17, pages 100973.
Crossref
Crossref
Victor Johan Bernard Huiskes, Johanna Everdina Vriezekolk, Cornelia Helena Maria van den Ende, Liset van Dijk & Bartholomeus Johannes Fredericus van den Bemt. (2022) Impact of physician’ and pharmacy staff supporting activities in usual care on patients’ statin adherence. PLOS ONE 17:2, pages e0264555.
Crossref
Crossref
Nicholas B. Hunt, Johanna E. Emmens, Sylvi Irawati, Stijn de Vos, Jens H.J. Bos, Bob WilffertEelko Hak & Rudolf A. de Boer. (2022) Sex disparities in the effect of statins on lipid parameters. Medicine 101:2, pages e28394.
Crossref
Crossref
Konstantinos Tsioufis, José María Castellano Vázquez, Georgia Sykara, Franco Mondello Malvestiti & Joris van Vugt. (2021) Real-world Evidence for Adherence and Persistence with Atorvastatin Therapy. Cardiology and Therapy 10:2, pages 445-464.
Crossref
Crossref
Steven E. Nissen, Howard G. Hutchinson, Tracy Y. Wang, Christie M. Ballantyne, Sara Travis, Melanie Morris, William Miller, Jennifer Hynson, Kathy Wolski & Paul M Ridker. (2021) Technology-Assisted Self-Selection of Candidates for Nonprescription Statin Therapy. Journal of the American College of Cardiology 78:11, pages 1114-1123.
Crossref
Crossref
François Schiele, Nadia Quignot, Artak Khachatryan, Gaelle Gusto, Guillermo Villa, Doreen Kahangire, Jean-Vannak Chauny, Lea Ricci & Gaelle Desamericq. (2021) Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: Five years of clinical follow-up from 164,565 post-myocardial infarction patients. International Journal of Cardiology 332, pages 22-28.
Crossref
Crossref
Ingo Ahrens, Artak Khachatryan, Bondo Monga, Eugen Dornstauder & Eduard Sidelnikov. (2021) Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany. Advances in Therapy 38:5, pages 2532-2541.
Crossref
Crossref
Sara Malo, María José Rabanaque, Lina Maldonado, Belén Moreno-Franco, Armando Chaure-Pardos, María Jesús Lallana, María Pilar Rodrigo & Isabel Aguilar-Palacio. (2021) Identifying Clusters of Adherence to Cardiovascular Risk Reduction Behaviors and Persistence with Medication in New Lipid-Lowering Drug Users. Impact on Healthcare Utilization. Nutrients 13:3, pages 723.
Crossref
Crossref
Siddhi Umarje, NehaM James, Priti Dave, Asawari Raut & Neha Pandey. (2021) Impact of adherence, patient perception, and knowledge to statin therapy – A cross-sectional study. Indian Journal of Endocrinology and Metabolism 25:3, pages 206.
Crossref
Crossref
Taoli Lu, Xu Yang, Yanli Cai, Chenchen Xie & Bei Zhang. (2021) Prestroke Statins Improve Prognosis of Atrial Fibrillation-Associated Stroke through Increasing Suppressor of Cytokine Signaling-3 Levels. European Neurology 84:2, pages 96-102.
Crossref
Crossref
Aisha Vadhariya, Rutugandha Paranjpe, Ekere J. Essien, Michael L. Johnson, Marc L. Fleming, Tara W. Esse, Esteban Gallardo, Omar Serna, Jeannie Choi, Susan Boklage & Susan M. Abughosh. (2021) Patient-reported barriers to statin adherence: Excerpts from a motivational interviewing intervention in older adults. Journal of the American Pharmacists Association 61:1, pages 60-67.e1.
Crossref
Crossref
Renata Cristina Rezende Macedo do Nascimento, Tanja Mueller, Brian Godman, Sean MacBride Stewart, Simon Hurding, Francisco de Assis Acurcio, Augusto Afonso Guerra Junior, Juliana Alvares Teodoro, Alec Morton, Marion Bennie & Amanj Kurdi. (2020) Real‐world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population‐based study. British Journal of Clinical Pharmacology 86:12, pages 2349-2361.
Crossref
Crossref
Isabel Aguilar-Palacio, María José Rabanaque, Lina Maldonado, Armando Chaure, José María Abad-Díez, Montse León-Latre, José Antonio Casasnovas & Sara Malo. (2020) New Male Users of Lipid-Lowering Drugs for Primary Prevention of Cardiovascular Disease: The Impact of Treatment Persistence on Morbimortality. A Longitudinal Study. International Journal of Environmental Research and Public Health 17:20, pages 7653.
Crossref
Crossref
Amirhossein Sahebkar, Arrigo F.G. Cicero, Paolo Di Giosia, Irene Pomilio, Cosimo Andrea Stamerra, Paolo Giorgini, Claudio Ferri, Stephan von Haehling, Maciej Banach & Tannaz Jamialahmadi. (2020) Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system. Journal of Cachexia, Sarcopenia and Muscle 11:5, pages 1177-1186.
Crossref
Crossref
Martínez-Sánchez Froylan D, Jorge-Galarza Esteban, Posadas-Romero Carlos, Medina-Urrutia Aida X, Martínez-Alvarado Ma Rocío, Osorio-Alonso Horacio & Juárez-Rojas Juan G. (2020) Prevalence of poor lipid control in patients with premature coronary artery disease. Nutrition, Metabolism and Cardiovascular Diseases 30:10, pages 1697-1705.
Crossref
Crossref
Areti Sofogianni & Konstantinos Tziomalos. (2020) Fixed‐dose combinations of lipid‐lowering and antihypertensive agents: The way forward?. The Journal of Clinical Hypertension 22:2, pages 270-272.
Crossref
Crossref
Christel Hero, Sofia Axia Karlsson, Stefan Franzén, Ann-Marie Svensson, Mervete Miftaraj, Soffia Gudbjörnsdottir, Karolina Andersson Sundell, Björn Eliasson & Katarina Eeg-Olofsson. (2020) Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register. BMJ Open Diabetes Research & Care 8:1, pages e000719.
Crossref
Crossref
Peter P. Toth, Craig Granowitz, Michael Hull, Amy Anderson & Sephy Philip. (2019) Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis. Lipids in Health and Disease 18:1.
Crossref
Crossref
Nir Madjar, Dan Shlosberg, Maya Leventer-Roberts, Amichay Akriv, Adi Ghilai, Moshe Hoshen, Amir Krivoy, Gil Zalsman & Gal Shoval. (2019) Childhood methylphenidate adherence as a predictor of antidepressants use during adolescence. European Child & Adolescent Psychiatry 28:10, pages 1365-1373.
Crossref
Crossref
Felicitas Kuehne, Beate Jahn, Annette Conrads-Frank, Marvin Bundo, Marjan Arvandi, Florian Endel, Niki Popper, Gottfried Endel, Christoph Urach, Michael Gyimesi, Eleanor J Murray, Goodarz Danaei, Thomas A Gaziano, Ankur Pandya & Uwe Siebert. (2019) Guidance for a causal comparative effectiveness analysis emulating a target trial based on big real world evidence: when to start statin treatment. Journal of Comparative Effectiveness Research 8:12, pages 1013-1025.
Crossref
Crossref
Mayumi Wake, Akinori Oh, Yoshie Onishi, Florent Guelfucci, Yukio Shimasaki & Tamio Teramoto. (2019) Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan. Atherosclerosis 282, pages 19-28.
Crossref
Crossref
Holly F. Hope, George M. Binkley, Sally Fenton, George D. Kitas, Suzanne M. M. Verstappen & Deborah P. M. Symmons. (2019) Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease. PLOS ONE 14:1, pages e0201196.
Crossref
Crossref
D. G. Gognieva, D. Yu. Shchekochikhin, E. V. Gavrilova, E. A. Syrkina, R. S. Bogdanova, A. L. Syrkin & Ph. Yu. Kopylov. (2019) The problem of adherence to treatment in general medical practice. Kardiologiya i serdechno-sosudistaya khirurgiya 12:6, pages 510.
Crossref
Crossref
Richard Ofori‐Asenso, Jenni Ilomäki, Mark Tacey, Si Si, Andrea J. Curtis, Ella Zomer, J. Simon Bell, Sophia Zoungas & Danny Liew. (2018) Predictors of first‐year nonadherence and discontinuation of statins among older adults: a retrospective cohort study. British Journal of Clinical Pharmacology 85:1, pages 227-235.
Crossref
Crossref
Kamlesh Khunti, Mark D. Danese, Lucie Kutikova, David Catterick, Francisco Sorio-Vilela, Michelle Gleeson, Sreenivasa Rao Kondapally Seshasai, Jack Brownrigg & Kausik K. Ray. (2018) Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe. JAMA Network Open 1:8, pages e185554.
Crossref
Crossref
Stefan Agewall. (2018) Adherence to guidelines, compliance to treatment, and treatment quality. European Heart Journal - Cardiovascular Pharmacotherapy 4:4, pages 189-190.
Crossref
Crossref
Alexander Vonbank, Heinz Drexel, Stefan Agewall, Basil S Lewis, Joern F Dopheide, Keld Kjeldsen, Claudio Ceconi, Gianluigi Savarese, Giuseppe Rosano, Sven Wassmann, Alexander Niessner, Thomas Andersen Schmidt, Christoph H Saely, Iris Baumgartner & Juan Tamargo. (2018) Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review. European Heart Journal - Cardiovascular Pharmacotherapy 4:4, pages 230-236.
Crossref
Crossref
Michel Rossignol, Michel Labrecque, Michel Cauchon, Marie-Claude Breton & Paul Poirier. (2018) Number of patients needed to prescribe statins in primary cardiovascular prevention: mirage and reality. Family Practice 35:4, pages 376-382.
Crossref
Crossref
Sabina De GeestLeah L. ZulligJacqueline Dunbar-JacobRemon HelmyDyfrig A. HughesIra B. WilsonBernard Vrijens. (2018) ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Annals of Internal Medicine 169:1, pages 30.
Crossref
Crossref
Mayumi Wake, Yoshie Onishi, Florent Guelfucci, Akinori Oh, Shinzo Hiroi, Yukio Shimasaki & Tamio Teramoto. (2018) Treatment patterns in hyperlipidaemia patients based on administrative claim databases in Japan. Atherosclerosis 272, pages 145-152.
Crossref
Crossref
Georgeta D. Vaidean, Marta Manczuk, Sandeep S. Vansal & Jacqueline Griffith. (2018) The cholesterol-lowering effect of statins is potentiated by whole grains intake. The Polish Norwegian Study (PONS). European Journal of Internal Medicine 50, pages 47-51.
Crossref
Crossref
Sofia Axia Karlsson, Christel Hero, Björn Eliasson, Stefan Franzén, Ann-Marie Svensson, Mervete Miftaraj, Soffia Gudbjörnsdottir, Katarina Eeg-Olofsson & Karolina Andersson Sundell. (2017) Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study. Pharmacoepidemiology and Drug Safety 26:10, pages 1220-1232.
Crossref
Crossref
Alexander C. FlintCarol ConellXiushui RenHooman KamelSheila L. ChanVivek A. RaoS. Claiborne Johnston. (2017) Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation. Stroke 48:7, pages 1788-1794.
Crossref
Crossref
Eun-Jung Rhee, Kyungdo Han, Seung-Hyun Ko, Kyung-Soo Ko & Won-Young Lee. (2017) Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: A nationwide population-based study. PLOS ONE 12:5, pages e0176615.
Crossref
Crossref